• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Edwards to sell critical care products unit to Becton Dickinson for $4.2 bln

cafead

Administrator
Staff member
  • cafead   Jun 03, 2024 at 12:12: PM
via Edwards Lifesciences (EW.N) on Monday said it has agreed to sell its critical care products unit to Becton Dickinson (BDX.N) in an all-cash deal valued at $4.2 billion to sharpen focus on its heart devices business.

article source